The present invention provides a novel compound represented by the formula (I) wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof having a superior GPR40 receptor function modulating action, which can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes and the like. They unexpectedly show superior GPR40 receptor agonist activity, and also show superior properties as a pharmaceutical product, such as stability and the like. Thus, they can be safe and useful pharmaceutical agents for the prophylaxis or treatment of GPR40 receptor related diseases in mammals.
本发明提供一种新型化合物,其表示为式(I),其中每个符号如规范中所定义,其盐和前药具有优越的GPR40受体功能调节作用,可用作
胰岛素分泌
促进剂、糖尿病预防或治疗剂等。它们意外地表现出优越的GPR40受体激动剂活性,并且还表现出优越的药物产品特性,如稳定性等。因此,它们可以作为安全和有用的药物剂量,用于哺乳动物的GPR40受体相关疾病的预防或治疗。